CASI Pharmaceuticals Inc. (CASI) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    CASI Pharmaceuticals Inc.

    NASDAQ: CASI · Real-Time Price · USD
    1.31
    -0.20 (-13.30%)
    At close: Sep 26, 2025, 3:59 PM
    1.32
    0.70%
    After-hours: Sep 26, 2025, 07:58 PM EDT

    CASI Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -1.11 -3.55 -0.62 -2.88
    PEG Ratio
    		 -0.04 0.12 -0.16 0.08
    PS Ratio
    		 1.52 2.82 0.57 3.61
    PB Ratio
    		 23.45 3.96 0.55 1.29
    P/FCF Ratio
    		 -1.47 -4.31 -0.91 -2.57
    P/OCF Ratio
    		 -1.49 -4.79 -1.16 -4.06
    OCF/S Ratio
    		 -1.02 -0.59 -0.49 -0.89
    Debt / Equity Ratio
    		 11.96 0.88 0.03 0.03
    Quick Ratio
    		 0.94 2.60 3.96 4.56
    Current Ratio
    		 1.09 3.55 4.32 4.70
    Asset Turnover
    		 0.53 0.45 0.45 0.22
    Interest Coverage
    		 -45.49 n/a -427.27 n/a
    Return on Equity
    		 -21.21 -1.11 -0.88 -0.45
    Return on Assets
    		 -0.73 -0.36 -0.41 -0.27
    Return on Invested Capital
    		 -1.12 -0.42 -0.35 -0.29
    Dividend Yield
    		 0.02 n/a n/a n/a
    Payout Ratio
    		 -0.02 n/a n/a n/a
    Gross Profit Margin
    		 0.39 0.59 0.63 0.58
    Net Profit Margin
    		 -1.38 -0.8 -0.91 -1.25
    Pretax Profit Margin
    		 -1.33 -0.78 -0.87 -1.19
    Operating Profit Margin
    		 -1.39 -0.74 -0.61 -1.17
    FCF Margin
    		 -1.03 -0.66 -0.62 -1.4
    EBITDA Margin
    		 -1.22 -0.64 -0.56 -1.09

    Add to Watchlist